EPHA5 Protein, Cynomolgus, Recombinant (His)
Product Specifications
Bioactivity
Ephrin type-A receptor 5 (EphA5) expression was detected in all non-tumor gastric epithelia but was differentially expressed among gastric cancer samples. EphA5 is differentially expressed in gastric cancer. EphA5 may therefore be a potential therapeutic target and may have clinical utility as a marker for lymph node metastasis in gastric cancer. EPHA5 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 61.73 kDa and the accession number is A0A2K5W6J6.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-272862 250 mg
1- (2-Diethylamino-ethyl) -1H-benzoimidazol-2-ylamine
Sign In for Pricing
View Details 
MBS1143234-01 0.02 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Anaphase-promoting complex subunit 13 (apc13)
Sign In for Pricing
View Details MBS1143234-02 0.1 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Anaphase-promoting complex subunit 13 (apc13)
Sign In for Pricing
View Details MBS1143234-03 0.02 mg (Yeast)
Recombinant Schizosaccharomyces pombe Anaphase-promoting complex subunit 13 (apc13)
Sign In for Pricing
View Details MBS1143234-04 0.1 mg (Yeast)
Recombinant Schizosaccharomyces pombe Anaphase-promoting complex subunit 13 (apc13)
Sign In for Pricing
View Details MBS1143234-05 0.02 mg (Baculovirus)
Recombinant Schizosaccharomyces pombe Anaphase-promoting complex subunit 13 (apc13)
Sign In for Pricing
View Details